Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Connolly

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Pediatric Neurology|September 26, 2020
Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional TestsNatalie F Miller, Lindsay N Alfano, Megan A Iammarino, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 25, 2015
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular DystrophiesChristopher F Spurney, Francis M McCaffrey, Avital Cnaan, et al.
Human Molecular Genetics|January 5, 2010
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1Christina A Gurnett, David M Desruisseau, Kevin McCall, et al.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
World Journal of Pediatrics : WJP|March 25, 2019
Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophyQing Ke, Zheng-Yan Zhao, Jerry R Mendell, et al.
Journal of Neuromuscular Diseases|June 14, 2021
Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI TrialCraig M McDonald, Perry B Shieh, Hoda Z Abdel-Hamid, et al.
Plos Currents|January 25, 2014
A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophyHugh D Allen, Kevin M Flanigan, Philip T Thrush, et al.
JAMA Neurology|May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical TrialPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Pediatric Neurology|July 16, 2021
Validity and Reliability of the Neuromuscular Gross Motor OutcomeLindsay N Alfano, Megan A Iammarino, Natalie F Reash, et al.
Muscle & Nerve|April 25, 2020
Spinal muscular atrophy care in the COVID-19 pandemic eraAravindhan Veerapandiyan, Anne M Connolly, Richard S Finkel, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Pediatric Neurology|September 26, 2020
Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional TestsNatalie F Miller, Lindsay N Alfano, Megan A Iammarino, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 25, 2015
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular DystrophiesChristopher F Spurney, Francis M McCaffrey, Avital Cnaan, et al.
Human Molecular Genetics|January 5, 2010
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1Christina A Gurnett, David M Desruisseau, Kevin McCall, et al.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
World Journal of Pediatrics : WJP|March 25, 2019
Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophyQing Ke, Zheng-Yan Zhao, Jerry R Mendell, et al.
Journal of Neuromuscular Diseases|June 14, 2021
Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI TrialCraig M McDonald, Perry B Shieh, Hoda Z Abdel-Hamid, et al.
Plos Currents|January 25, 2014
A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophyHugh D Allen, Kevin M Flanigan, Philip T Thrush, et al.
JAMA Neurology|May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical TrialPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Pediatric Neurology|July 16, 2021
Validity and Reliability of the Neuromuscular Gross Motor OutcomeLindsay N Alfano, Megan A Iammarino, Natalie F Reash, et al.
Muscle & Nerve|April 25, 2020
Spinal muscular atrophy care in the COVID-19 pandemic eraAravindhan Veerapandiyan, Anne M Connolly, Richard S Finkel, et al.
Pageof 12